EGFR and neoplasm: Targeted sequencing was performed on paired CSF and blood samples collected at LM diagnosis from patients with either EGFR exon 19 deletion (19del) (n = 19) or EGFR exon 21 L858R (n = 26) detected from their tumor samples at baseline (before developing LM).